Literature DB >> 23333166

Echocardiography and vascular ultrasound: new developments and future directions.

Robin Ducas1, Wendy Tsang, Adrian A Chong, Davinder S Jassal, Roberto M Lang, Howard Leong-Poi, Kwan Leung Chan.   

Abstract

There have been major technological advances in echocardiography over the past decade. New and robust measures of myocardial function, both systolic and diastolic, have been identified and extensively evaluated. Some of the new measures such as annular velocities by tissue Doppler imaging have become an integral part of the echocardiographic examination, and other measures such as strain and strain rate have yet to be widely adopted. Three-dimensional (3D) echocardiography has evolved greatly since its introduction in the 1980s. Currently, its main clinical application is the perioperative assessment of the mitral valve. Though 3D echocardiography provides superior quantification of cardiac chamber size, its adoption has been limited by the lack of robust automated data analysis software with smooth integration of analysis packages into clinical workstations and suboptimal temporal and spatial resolution. With advancement in electronics and miniaturization, these limitations can be overcome. The history of contrast echocardiography is long and arduous. Use of a microbubble contrast for left ventricular opacification has become commonplace in most echocardiographic laboratories, but the routine use of microbubble contrast for myocardial perfusion will require standardization of the procedure and/or development of new contrast agents. The applications of 3D and microbubble contrast are also under active evaluation in vascular ultrasound. This review summarizes the current and future applications of these exciting developments in echocardiography and vascular ultrasound.
Copyright © 2013 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23333166     DOI: 10.1016/j.cjca.2012.11.001

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  6 in total

1.  Three-dimensional compared to two-dimensional transesophageal echocardiography for diagnosis of infective endocarditis.

Authors:  Roman Pfister; Yann Betton; Henrik Ten Freyhaus; Norma Jung; Stephan Baldus; Guido Michels
Journal:  Infection       Date:  2016-05-17       Impact factor: 3.553

2.  Exploring the vascular smooth muscle receptor landscape in vivo: ultrasound Doppler versus near-infrared spectroscopy assessments.

Authors:  Stephen J Ives; Paul J Fadel; R Matthew Brothers; Mikael Sander; D Walter Wray
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

Review 3.  Multimodality Imaging in Ischemic Cardiomyopathy.

Authors:  John O Prior; Hoshang Farhad; Olivier Muller
Journal:  Curr Cardiovasc Imaging Rep       Date:  2014

4.  Assessment of left ventricular function in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease using three-dimensional speckle-tracking echocardiography.

Authors:  Yu Dong; Hongyan Cui; Lihua Sun; Ying Wang; Ying Li; Wenxing Chang; Guangsen Li; Dongmei Huang
Journal:  Anatol J Cardiol       Date:  2020-01       Impact factor: 1.596

5.  Is the Increased Septal Perfusion the Signal of Asymmetrical Septal Hypertrophy?

Authors:  Semra Ozdemir; Yusuf Ziya Tan; Emine Gazi
Journal:  World J Nucl Med       Date:  2016-09

6.  Aging Science Talks: The role of miR-181a in age-related loss of muscle mass and function.

Authors:  Maria Borja-Gonzalez; Jose C Casas-Martinez; Brian McDonagh; Katarzyna Goljanek-Whysall
Journal:  Transl Med Aging       Date:  2020-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.